Combination Cancer Immunotherapy with Molecular Targeted Agents/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma.

ABSTRACT:

SUBMITTER: Kudo M 

PROVIDER: S-EPMC6388565 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature